GlassScriptPhysician profile
Vishal B Patel
NPI 1437147477
$15,913.23
in general payments reported to CMS, 2019-2025
21 companies · $1,116 in 2025
The $1,116 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $268 · 2021: $599 · 2022: $393 · 2023: $901 · 2024: $822 · 2025: $1,116.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,839.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,838.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $11,820.38 | 2019-2024 | |
| Abbott Laboratories | $1,929.65 | 2020-2025 | Cardiomems, Mitraclip, Proclaim |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $555.55 | 2019-2025 | Lifevest |
| Abiomed | $475.69 | 2024-2025 | Impella |
| Zoll Circulation INC | $116.99 | 2023 | Downstream Cartridge, Therox Ds2 Console, Catheter |
| Medtronic, INC. | $109.74 | 2021-2025 | Venaseal |
| Cleerly, INC. | $108.62 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Biosense Webster, INC. | $102.75 | 2024 | Carto 3 |
| Boston Scientific Corporation | $97.32 | 2025 | General - Brady, General - Therapies |
| Janssen Pharmaceuticals, INC | $91.83 | 2021-2024 | Xarelto |
| Pfizer INC. | $71.87 | 2025 | |
| Merck Sharp & Dohme LLC | $68.44 | 2021-2025 | Verquvo |
| Astrazeneca Pharmaceuticals LP | $60.12 | 2021-2024 | Farxiga |
| Inspire Medical Systems, INC. | $60.02 | 2025 | Inspire |
| Amgen INC. | $52.63 | 2019-2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $46.10 | 2024 | Assure Wcd |
| Bardy Diagnostics, INC. | $45.00 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $36.35 | 2020-2023 | Jardiance |
| Astellas Pharma US INC | $32.99 | 2025 | Izervay |
| Impulse Dynamics (USA) INC. | $15.88 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $15.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vishal Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.